INDV Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: March 02, 2026
Report Source: 2025 Annual Report
Indivior Pharmaceuticals, Inc. Stock Analysis INDV
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The company sells its products in the United States and in other selected areas of the world.
Read More Indivior Pharmaceuticals, Inc (INDV) Chart
Key Statistics of Indivior Pharmaceuticals, Inc (INDV)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$37.51Volume
1.82MP/E Ratio (TTM)
21.3452 Week Range
Market Cap
4.83BAvg. Volume
2.24MDividend Yield
-Financial Metrics & Statements of Indivior Pharmaceuticals, Inc (INDV)
FAQ's for Indivior Pharmaceuticals, Inc (INDV)
- According to Musaffa’s Shariah screening methodology, Indivior Pharmaceuticals, Inc (INDV) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.